SlideShare una empresa de Scribd logo
1 de 13
Chemical & Drug Injuries
Chemical & drug injuries
***All chemicals & drugs are capable of causing injury or
death.***
accidental exposure
self-administration
accidental overdose
non-medical use of street drugs
unanticipated result of self-administered or prescribed use
of standard medicines.
exaggeration of an intended pharmacologic effect or an
accompanying side effect
Adverse drug reactions (ADRs)
 any response to a drug that is noxious & unintended,
occurring at doses used in humans for prophylaxis,
diagnosis, or therapy, excluding failure to accomplish the
intended purpose; [mechanisms: direct toxicity to cells;
immunologic/idiosyncratic reactions; or due to
↓immunologic / hormonal host defenses]
Predictable ADRs: known side-effects; dose-related, severity
depends on route of administration
Unpredictable ADRs: unanticipated, usually immunologic,
idiosyncratic; dose & route of administration do not affect the
severity
Therapeutic agents
ANALGESICS
 Aspirin
 Aspirin + Phenacetin
 NSAIDS (non-steroidal anti-inflammatory drugs):
Ibuprofen, Diclofenac,
 Acetaminophen/Paracetamol
ANTIMICROBIALS
ANTI-NEOPLASTIC AGENTS
 Anti-metabolites
 Immunosuppressives
Therapeutic agents: aspirin
Therapeutic dose: 0.5-1.0 gm./day
Lethal dose: 2-4 gm./day in children
10-30 gm./day in adults
Acute toxicity: initial alkalosis--- fluid & electrolyte
imbalance--- metabolic acidosis--- death
Chronic toxicity: (3 gm/day): dizziness, nausea, vomiting,
diarrhea, drowsiness, hallucinations, convulsions, coma
Known effects: analgesic; anti-platelet aggregation; gastric
irritant--- acute erosive gastritis
Unpredictable ADRs: hypersensitivity: rashes, urticaria,
exfoliative dermatoses
Therapeutic agents: analgesics
Aspirin + Phenacetin
 Toxicity: nephropathy : renal papillary necrosis
NSAIDS:
 known side effect: gastric irritation;
 UADR: hypersensitivity
Acetaminophen:
 therapeutic dose: 0.5 gm q 4 hrs.(up to 3gm/day)
 toxic dose: 15-25 gm;
 toxicity: nausea, vomiting, diarrhea; shock; hepatic
injury
 pathology: hepatic necrosis; renal/myocardial
damage
Therapeutic agents: anti-neoplastics
Anti-metabolites
 Bone marrow suppression
 GI mucosal injury
 Hair follicle injury
 Immunosuppression
 Nonlethal mutations
 Initiation of some form of Cancer
Immunosuppressives
 ↑ susceptibility to infections, esp. opportunistic
 ↑ risk of malignant lymphoma
Therapeutic agents:
antimicrobials/antibiotics
Hypersensitivity
 rashes, urticaria, exfoliative dermatoses
 anaphylaxis
Emergence of microbial resistance
 “super-infections”
Eradication of normal flora
 vitamin K deficiency--- bleeding diathesis
Adverse drug reactions
 BLOOD (DYSCRACIAS)
 Granulocytopenia
 Aplastic anemia
 Pancytopenia
 Hemolytic anemia
 thrombocytopenia
 CNS
 Tinnitus, dizziness
 Acute dystonic reactions
 Parkinson’s syndrome
 CUTANEOUS
 Urticaria
 Petechia
 Exfoliative dermatitis
 BLOOD DYSCRACIAS
 Anti-neoplastics
 Immunosuppressants
 Chloramphenicol
 Quinidine
 Methyldopa
 CNS
 Salicylates
 Phenothiazine
antipsychotics
 Sedatives
 CUTANEOUS
 Sulfonamides
 Hydantoin
 Anti-neoplastics
Adverse drug reactions
 CARDIAC
 Arrhythmias
 Cardiomyopathy
 HEPATIC
 Fatty change
 Cholestasis
 Hepatocellular
damage
 PULMONARY
 Acute Pneumonitis
 Interstitial fibrosis
 Asthma
 CARDIAC
 Theophylline
 Hydantoin
 Doxorubicin, Daunorubicin
 HEPATIC
 Tetracycline
 Chlorpromazine, Estrogens
 Halothane,
Acetaminophen, INH
 PULMONARY
 Salicylates
 Nitrofurantoin
 Busulfan, Bleomycin
Adverse drug reactions
RENAL
 Glomerulonephritis
 Tubulointerstitial
nephritis
 Acute tubular nephritis
SYSTEMIC
 Anaphylaxis
 Lupus erythematosus
syndrome
RENAL
 Penicillamine
 Phenacetin
 Salicylates
 Aminoglycosides,
Cyclosporine,
Amphotericin B
SYSTEMIC
 Penicillin, Aspirin
 Hydralazine,
Procainamide
Fatal drug reactions
Tricyclic anti-depressants
 Alprazolam
 Ipramine, Desipramine
 Nortriptyline
Acetaminophen
Halothane
Aspirin
CNS depression
Hepatic necrosis
Hepatic necrosis
Metabolic acidosis; Fluid &
Electrolyte imbalance
Thank you !

Más contenido relacionado

La actualidad más candente

Rheumatoid arthritis medications Tips
Rheumatoid arthritis medications TipsRheumatoid arthritis medications Tips
Rheumatoid arthritis medications TipsEmergency Drug
 
Phenytoin Toxicity
Phenytoin Toxicity Phenytoin Toxicity
Phenytoin Toxicity Ade Wijaya
 
12.drugs used in rheumatoid arthritis and gout
12.drugs used in rheumatoid arthritis and gout 12.drugs used in rheumatoid arthritis and gout
12.drugs used in rheumatoid arthritis and gout Dr.Manish Kumar
 
Status of dmards in rheumatoid arthritis
Status of dmards in rheumatoid arthritisStatus of dmards in rheumatoid arthritis
Status of dmards in rheumatoid arthritisDr Sourya M
 
Drug induced skin disorders
Drug induced skin disordersDrug induced skin disorders
Drug induced skin disordersJuliaWilson68
 
Rheumatoid arthritis : Biological DMARDs
Rheumatoid arthritis : Biological DMARDsRheumatoid arthritis : Biological DMARDs
Rheumatoid arthritis : Biological DMARDsSRUTHI N
 
Neuroleptic malignant syndrome
Neuroleptic malignant syndromeNeuroleptic malignant syndrome
Neuroleptic malignant syndromeMarvin Bayog
 
Chemotherapy induced disorders by sara ahmed yadallah
Chemotherapy induced disorders by sara ahmed yadallahChemotherapy induced disorders by sara ahmed yadallah
Chemotherapy induced disorders by sara ahmed yadallahPARUL UNIVERSITY
 
Pharmacotherapy of epilepsy
Pharmacotherapy of epilepsyPharmacotherapy of epilepsy
Pharmacotherapy of epilepsyDr Swaroop HS
 
Anti-Rheumatic drugs
Anti-Rheumatic drugsAnti-Rheumatic drugs
Anti-Rheumatic drugsJagirPatel3
 
Anti epileptic drugs
Anti epileptic drugsAnti epileptic drugs
Anti epileptic drugssanu108
 
Pharmacotheparapy of epilepsy
Pharmacotheparapy of epilepsyPharmacotheparapy of epilepsy
Pharmacotheparapy of epilepsyshubhangi buchade
 

La actualidad más candente (20)

DMARDs
DMARDsDMARDs
DMARDs
 
Rheumatoid arthritis medications Tips
Rheumatoid arthritis medications TipsRheumatoid arthritis medications Tips
Rheumatoid arthritis medications Tips
 
Phenytoin Toxicity
Phenytoin Toxicity Phenytoin Toxicity
Phenytoin Toxicity
 
12.drugs used in rheumatoid arthritis and gout
12.drugs used in rheumatoid arthritis and gout 12.drugs used in rheumatoid arthritis and gout
12.drugs used in rheumatoid arthritis and gout
 
Antirheumatic drugs
Antirheumatic drugsAntirheumatic drugs
Antirheumatic drugs
 
Phenytoin
PhenytoinPhenytoin
Phenytoin
 
Status of dmards in rheumatoid arthritis
Status of dmards in rheumatoid arthritisStatus of dmards in rheumatoid arthritis
Status of dmards in rheumatoid arthritis
 
Medications in the elderly
Medications in the elderlyMedications in the elderly
Medications in the elderly
 
Dmards by fasel rafiq
Dmards by fasel rafiqDmards by fasel rafiq
Dmards by fasel rafiq
 
Diet therapy
Diet therapyDiet therapy
Diet therapy
 
Drug induced skin disorders
Drug induced skin disordersDrug induced skin disorders
Drug induced skin disorders
 
Rheumatoid arthritis : Biological DMARDs
Rheumatoid arthritis : Biological DMARDsRheumatoid arthritis : Biological DMARDs
Rheumatoid arthritis : Biological DMARDs
 
Neuroleptic malignant syndrome
Neuroleptic malignant syndromeNeuroleptic malignant syndrome
Neuroleptic malignant syndrome
 
Chemotherapy induced disorders by sara ahmed yadallah
Chemotherapy induced disorders by sara ahmed yadallahChemotherapy induced disorders by sara ahmed yadallah
Chemotherapy induced disorders by sara ahmed yadallah
 
Pharmacotherapy of epilepsy
Pharmacotherapy of epilepsyPharmacotherapy of epilepsy
Pharmacotherapy of epilepsy
 
Anti-Rheumatic drugs
Anti-Rheumatic drugsAnti-Rheumatic drugs
Anti-Rheumatic drugs
 
Anti epileptic drugs
Anti epileptic drugsAnti epileptic drugs
Anti epileptic drugs
 
Neuroleptic malignant syndrome
Neuroleptic malignant syndromeNeuroleptic malignant syndrome
Neuroleptic malignant syndrome
 
Dress
DressDress
Dress
 
Pharmacotheparapy of epilepsy
Pharmacotheparapy of epilepsyPharmacotheparapy of epilepsy
Pharmacotheparapy of epilepsy
 

Destacado

BoEx papp nº 2
BoEx papp nº 2BoEx papp nº 2
BoEx papp nº 2Barragome
 
Pharma drugprescription
Pharma drugprescriptionPharma drugprescription
Pharma drugprescriptionnowienajoyce
 
Cm3 safety in the lab
Cm3 safety in the labCm3 safety in the lab
Cm3 safety in the labnowienajoyce
 
The ban on phenacetin is associated with changes in the incidence trends of u...
The ban on phenacetin is associated with changes in the incidence trends of u...The ban on phenacetin is associated with changes in the incidence trends of u...
The ban on phenacetin is associated with changes in the incidence trends of u...Cancer Council NSW
 
Polimedicado enfermería (Mª Luz Rubio)
Polimedicado enfermería (Mª Luz Rubio)Polimedicado enfermería (Mª Luz Rubio)
Polimedicado enfermería (Mª Luz Rubio)Barragome
 
Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...
Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...
Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...Stefania Dumitrescu
 
Paracetamol
ParacetamolParacetamol
Paracetamolpedrofmo
 
Aspirin synthesis ppt
Aspirin synthesis pptAspirin synthesis ppt
Aspirin synthesis pptShiva Reddy
 
Physico-chemical Properties Affecting Drug Formulation.
Physico-chemical Properties Affecting Drug Formulation.Physico-chemical Properties Affecting Drug Formulation.
Physico-chemical Properties Affecting Drug Formulation.Muavia Sarwar
 
Paracetamol information ppt
Paracetamol information pptParacetamol information ppt
Paracetamol information pptMilan Padariya
 
Paracetamol - widening the horizon in pain managment
Paracetamol - widening the horizon in pain managmentParacetamol - widening the horizon in pain managment
Paracetamol - widening the horizon in pain managmentGiridhar Panpalia
 

Destacado (19)

Pharma doa
Pharma doaPharma doa
Pharma doa
 
BoEx papp nº 2
BoEx papp nº 2BoEx papp nº 2
BoEx papp nº 2
 
Pharma drugprescription
Pharma drugprescriptionPharma drugprescription
Pharma drugprescription
 
Cm3 safety in the lab
Cm3 safety in the labCm3 safety in the lab
Cm3 safety in the lab
 
Intro pharma
Intro pharmaIntro pharma
Intro pharma
 
The ban on phenacetin is associated with changes in the incidence trends of u...
The ban on phenacetin is associated with changes in the incidence trends of u...The ban on phenacetin is associated with changes in the incidence trends of u...
The ban on phenacetin is associated with changes in the incidence trends of u...
 
Polimedicado enfermería (Mª Luz Rubio)
Polimedicado enfermería (Mª Luz Rubio)Polimedicado enfermería (Mª Luz Rubio)
Polimedicado enfermería (Mª Luz Rubio)
 
M & p
M & pM & p
M & p
 
Cm6 ua intro
Cm6 ua introCm6 ua intro
Cm6 ua intro
 
Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...
Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...
Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...
 
dr.Husni - paracetamol iv as a safety analgesic
dr.Husni - paracetamol iv as a safety analgesicdr.Husni - paracetamol iv as a safety analgesic
dr.Husni - paracetamol iv as a safety analgesic
 
Paracetamol
ParacetamolParacetamol
Paracetamol
 
Aspirin synthesis ppt
Aspirin synthesis pptAspirin synthesis ppt
Aspirin synthesis ppt
 
Physico-chemical Properties Affecting Drug Formulation.
Physico-chemical Properties Affecting Drug Formulation.Physico-chemical Properties Affecting Drug Formulation.
Physico-chemical Properties Affecting Drug Formulation.
 
Paracetamol overdose
Paracetamol overdoseParacetamol overdose
Paracetamol overdose
 
Paracetamol toxicity
Paracetamol toxicityParacetamol toxicity
Paracetamol toxicity
 
Paracetamol information ppt
Paracetamol information pptParacetamol information ppt
Paracetamol information ppt
 
Paracetamol - widening the horizon in pain managment
Paracetamol - widening the horizon in pain managmentParacetamol - widening the horizon in pain managment
Paracetamol - widening the horizon in pain managment
 
Aspirin
AspirinAspirin
Aspirin
 

Similar a Chem&druginjuries

adverse drug reactions and adrs monitoring
adverse drug reactions and adrs monitoringadverse drug reactions and adrs monitoring
adverse drug reactions and adrs monitoringRaj Kumar
 
Iatrogenic disorders 1
Iatrogenic disorders 1Iatrogenic disorders 1
Iatrogenic disorders 1KshitijMankar
 
Adverse Drug reaction ppt
Adverse Drug reaction ppt Adverse Drug reaction ppt
Adverse Drug reaction ppt ShikhaSachde
 
Adverse drug reaction
Adverse   drug  reactionAdverse   drug  reaction
Adverse drug reactionViraj Shinde
 
Adverse drug reaction ,pharmacy practice
Adverse drug reaction ,pharmacy practiceAdverse drug reaction ,pharmacy practice
Adverse drug reaction ,pharmacy practiceDeepali69
 
Adverese drug effects
Adverese drug effectsAdverese drug effects
Adverese drug effectsChintan Doshi
 
Carcinogenesis
Carcinogenesis Carcinogenesis
Carcinogenesis WHO
 
Adverse drug reaction sjk
Adverse drug reaction sjkAdverse drug reaction sjk
Adverse drug reaction sjkshailajakamble3
 
5ee1 adverse drug reaction
5ee1 adverse drug reaction5ee1 adverse drug reaction
5ee1 adverse drug reactionAmira Badr
 
adr ppt (2).ppt
adr ppt (2).pptadr ppt (2).ppt
adr ppt (2).pptsumiaru
 
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICE
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICEAdverse Drug Reaction and Drug Interaction_PHARMACY PRACTICE
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICErishi2789
 
Adverse drug reaction and reporting
Adverse drug reaction and reportingAdverse drug reaction and reporting
Adverse drug reaction and reportingRupali Patil
 
adverse drug rxn.ppt
adverse drug rxn.pptadverse drug rxn.ppt
adverse drug rxn.pptSeema Bansal
 

Similar a Chem&druginjuries (20)

Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
adverse drug reactions and adrs monitoring
adverse drug reactions and adrs monitoringadverse drug reactions and adrs monitoring
adverse drug reactions and adrs monitoring
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
 
Iatrogenic disorders 1
Iatrogenic disorders 1Iatrogenic disorders 1
Iatrogenic disorders 1
 
Adverse Drug reaction ppt
Adverse Drug reaction ppt Adverse Drug reaction ppt
Adverse Drug reaction ppt
 
Adverse drug reaction
Adverse   drug  reactionAdverse   drug  reaction
Adverse drug reaction
 
Adverse drug reaction ,pharmacy practice
Adverse drug reaction ,pharmacy practiceAdverse drug reaction ,pharmacy practice
Adverse drug reaction ,pharmacy practice
 
Adverese drug effects
Adverese drug effectsAdverese drug effects
Adverese drug effects
 
Carcinogenesis
Carcinogenesis Carcinogenesis
Carcinogenesis
 
5.ppt
5.ppt5.ppt
5.ppt
 
ADRs.ppt
ADRs.pptADRs.ppt
ADRs.ppt
 
Ioatrogenic disease
Ioatrogenic disease Ioatrogenic disease
Ioatrogenic disease
 
Adverse drug reaction ppt
Adverse drug reaction pptAdverse drug reaction ppt
Adverse drug reaction ppt
 
Adverse drug reaction sjk
Adverse drug reaction sjkAdverse drug reaction sjk
Adverse drug reaction sjk
 
ADR
ADR ADR
ADR
 
5ee1 adverse drug reaction
5ee1 adverse drug reaction5ee1 adverse drug reaction
5ee1 adverse drug reaction
 
adr ppt (2).ppt
adr ppt (2).pptadr ppt (2).ppt
adr ppt (2).ppt
 
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICE
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICEAdverse Drug Reaction and Drug Interaction_PHARMACY PRACTICE
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICE
 
Adverse drug reaction and reporting
Adverse drug reaction and reportingAdverse drug reaction and reporting
Adverse drug reaction and reporting
 
adverse drug rxn.ppt
adverse drug rxn.pptadverse drug rxn.ppt
adverse drug rxn.ppt
 

Más de nowienajoyce

Más de nowienajoyce (12)

Cm5 renal function
Cm5 renal functionCm5 renal function
Cm5 renal function
 
Cm4 microscopy
Cm4 microscopyCm4 microscopy
Cm4 microscopy
 
Cm2 principles of qa
Cm2 principles of qaCm2 principles of qa
Cm2 principles of qa
 
Cm1 orientation
Cm1 orientationCm1 orientation
Cm1 orientation
 
Pharmacokinetics2
Pharmacokinetics2Pharmacokinetics2
Pharmacokinetics2
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Intro pharma
Intro pharmaIntro pharma
Intro pharma
 
Pharma toxicology
Pharma toxicologyPharma toxicology
Pharma toxicology
 
Pharma drugform
Pharma drugformPharma drugform
Pharma drugform
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Pharmacokinetics2
Pharmacokinetics2Pharmacokinetics2
Pharmacokinetics2
 
Pharma chemmediators
Pharma chemmediatorsPharma chemmediators
Pharma chemmediators
 

Chem&druginjuries

  • 1. Chemical & Drug Injuries
  • 2. Chemical & drug injuries ***All chemicals & drugs are capable of causing injury or death.*** accidental exposure self-administration accidental overdose non-medical use of street drugs unanticipated result of self-administered or prescribed use of standard medicines. exaggeration of an intended pharmacologic effect or an accompanying side effect
  • 3. Adverse drug reactions (ADRs)  any response to a drug that is noxious & unintended, occurring at doses used in humans for prophylaxis, diagnosis, or therapy, excluding failure to accomplish the intended purpose; [mechanisms: direct toxicity to cells; immunologic/idiosyncratic reactions; or due to ↓immunologic / hormonal host defenses] Predictable ADRs: known side-effects; dose-related, severity depends on route of administration Unpredictable ADRs: unanticipated, usually immunologic, idiosyncratic; dose & route of administration do not affect the severity
  • 4. Therapeutic agents ANALGESICS  Aspirin  Aspirin + Phenacetin  NSAIDS (non-steroidal anti-inflammatory drugs): Ibuprofen, Diclofenac,  Acetaminophen/Paracetamol ANTIMICROBIALS ANTI-NEOPLASTIC AGENTS  Anti-metabolites  Immunosuppressives
  • 5. Therapeutic agents: aspirin Therapeutic dose: 0.5-1.0 gm./day Lethal dose: 2-4 gm./day in children 10-30 gm./day in adults Acute toxicity: initial alkalosis--- fluid & electrolyte imbalance--- metabolic acidosis--- death Chronic toxicity: (3 gm/day): dizziness, nausea, vomiting, diarrhea, drowsiness, hallucinations, convulsions, coma Known effects: analgesic; anti-platelet aggregation; gastric irritant--- acute erosive gastritis Unpredictable ADRs: hypersensitivity: rashes, urticaria, exfoliative dermatoses
  • 6. Therapeutic agents: analgesics Aspirin + Phenacetin  Toxicity: nephropathy : renal papillary necrosis NSAIDS:  known side effect: gastric irritation;  UADR: hypersensitivity Acetaminophen:  therapeutic dose: 0.5 gm q 4 hrs.(up to 3gm/day)  toxic dose: 15-25 gm;  toxicity: nausea, vomiting, diarrhea; shock; hepatic injury  pathology: hepatic necrosis; renal/myocardial damage
  • 7. Therapeutic agents: anti-neoplastics Anti-metabolites  Bone marrow suppression  GI mucosal injury  Hair follicle injury  Immunosuppression  Nonlethal mutations  Initiation of some form of Cancer Immunosuppressives  ↑ susceptibility to infections, esp. opportunistic  ↑ risk of malignant lymphoma
  • 8. Therapeutic agents: antimicrobials/antibiotics Hypersensitivity  rashes, urticaria, exfoliative dermatoses  anaphylaxis Emergence of microbial resistance  “super-infections” Eradication of normal flora  vitamin K deficiency--- bleeding diathesis
  • 9. Adverse drug reactions  BLOOD (DYSCRACIAS)  Granulocytopenia  Aplastic anemia  Pancytopenia  Hemolytic anemia  thrombocytopenia  CNS  Tinnitus, dizziness  Acute dystonic reactions  Parkinson’s syndrome  CUTANEOUS  Urticaria  Petechia  Exfoliative dermatitis  BLOOD DYSCRACIAS  Anti-neoplastics  Immunosuppressants  Chloramphenicol  Quinidine  Methyldopa  CNS  Salicylates  Phenothiazine antipsychotics  Sedatives  CUTANEOUS  Sulfonamides  Hydantoin  Anti-neoplastics
  • 10. Adverse drug reactions  CARDIAC  Arrhythmias  Cardiomyopathy  HEPATIC  Fatty change  Cholestasis  Hepatocellular damage  PULMONARY  Acute Pneumonitis  Interstitial fibrosis  Asthma  CARDIAC  Theophylline  Hydantoin  Doxorubicin, Daunorubicin  HEPATIC  Tetracycline  Chlorpromazine, Estrogens  Halothane, Acetaminophen, INH  PULMONARY  Salicylates  Nitrofurantoin  Busulfan, Bleomycin
  • 11. Adverse drug reactions RENAL  Glomerulonephritis  Tubulointerstitial nephritis  Acute tubular nephritis SYSTEMIC  Anaphylaxis  Lupus erythematosus syndrome RENAL  Penicillamine  Phenacetin  Salicylates  Aminoglycosides, Cyclosporine, Amphotericin B SYSTEMIC  Penicillin, Aspirin  Hydralazine, Procainamide
  • 12. Fatal drug reactions Tricyclic anti-depressants  Alprazolam  Ipramine, Desipramine  Nortriptyline Acetaminophen Halothane Aspirin CNS depression Hepatic necrosis Hepatic necrosis Metabolic acidosis; Fluid & Electrolyte imbalance